A Pill is OTC?

The proverbial ‘pill’ or hormonal contraception may be available over-the-counter (or at least a progestin-only version) by year’s end. Join guest host, Jake Galdo, as he discusses improved access to care with Erin Raney as the FDA debates over-the-counter status for hormonal contraceptives.The GameChangerWomen’s health is a priority area from a public health perspective – the US has lots of room for improvement. One initiative is to allow a progestin-only hormonal contraceptive have over-the-counter status; in other words, be available without a prescription. Progestin-only therapy has unique counseling considerations, so pharmacy intervention can help to optimize care. HostJake Galdo, PharmD, MBA, BCPS, BCGPCourse Content and Developer, CEimpactManaging Network Facilitator, CPESN Health EquityCEO, SeguridadGuestErin C. Raney, Pharm.D., BCPS, BC-ADMProfessor of Pharmacy PracticeMidwestern University College of Pharmacy-GlendaleReferences and ResourcesOpill Rx-to-OTC Switch Program. www.fda.gov/media/167893/downloadPharmacist Members, REDEEM YOUR CPE HERE!Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the efficacy of OTC hormonal contraceptive2. Identify contraindications for OTC hormonal contraceptives0.05 CEU/0.5 HrUAN: 0107-0000-23-211-H01-PInitial release date: 5/29/2023Expiration date: 5/29/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram